Update of the treatment of nosocomial pneumonia in the ICU

R Zaragoza, P Vidal-Cortés, G Aguilar, M Borges… - Critical Care, 2020 - Springer
In accordance with the recommendations of, amongst others, the Surviving Sepsis
Campaign and the recently published European treatment guidelines for hospital-acquired …

Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects

A Zumla, JA Al-Tawfiq, VI Enne, M Kidd… - The Lancet Infectious …, 2014 - thelancet.com
Respiratory tract infections rank second as causes of adult and paediatric morbidity and
mortality worldwide. Respiratory tract infections are caused by many different bacteria …

Complications after prostate biopsy: data from SEER-Medicare

S Loeb, HB Carter, SI Berndt, W Ricker… - The Journal of …, 2011 - auajournals.org
Purpose: More than 1 million prostate biopsies are performed annually among Medicare
beneficiaries. We determined the risk of serious complications requiring hospitalization. We …

Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms

JI Barrasa-Villar, C Aibar-Remón… - Clinical Infectious …, 2017 - academic.oup.com
Background Infections by multidrug-resistant organisms (MDROs) are a global threat and
are particularly common in hospitals. This study was performed to assess the impact of …

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009 …

HS Sader, DJ Farrell, RK Flamm, RN Jones - Diagnostic microbiology and …, 2014 - Elsevier
Abstract Treatment of infections in the intensive care unit (ICU) represents a great challenge,
especially those caused by Gram-negative organisms. Rapid introduction of appropriate …

Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis

J Rodríguez-Baño, E Picón, P Gijón… - Clinical infectious …, 2010 - academic.oup.com
Background There is little clinical information about community-onset bloodstream infections
(COBSIs) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli …

Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front

MH Kollef - Clinical Infectious Diseases, 2008 - academic.oup.com
The treatment of serious bacterial infections is complicated by the fact that time to initiation of
effective antimicrobial therapy is a strong predictor of mortality. Therefore, therapy must be …

Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU

MH Tsai, SM Chu, JF Hsu, R Lien, HR Huang… - …, 2014 - publications.aap.org
OBJECTIVES: To assess the risk factors antibiotic therapy and outcomes of multidrug-
resistant (MDR) Gram-negative bacilli (GNB) bacteremia in NICU patients. METHODS …

Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?

KZ Vardakas, PI Rafailidis, AA Konstantelias… - Journal of Infection, 2013 - Elsevier
OBJECTIVE: To study the predictors of mortality among patients with multi-drug resistant
Gram negative (MDRGN) infections and the role of MDRGN bacteria in the outcome of such …

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy

M Tumbarello, T Spanu, R Di Bidino… - Antimicrobial agents …, 2010 - Am Soc Microbiol
Escherichia coli is the leading cause of bloodstream infections (BSIs) caused by Gram-
negative bacteria. The increasing prevalence of antibiotic-resistant E. coli strains …